AURELIE DE SCHIFFART | au
1
archive,paged,author,author-au,author-1,paged-250,author-paged-250,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-10.0,wpb-js-composer js-comp-ver-4.11.2,vc_responsive

The following table lists the incidence of all adverse events whether considered by the investigator drug related or unrelated to drug from this study which occurred at a rate of 3 or greater in the proventil hfa inhalation aerosol treatment group and more frequently in the proventil hfa inhalation aerosol treatment group than in the placebo group.